DiseaseModifying

TORONTO, July 06, 2023 (GLOBE NEWSWIRE) -- The Alzheimer Society of Ontario welcomes today’s US FDA decision to grant full approval to lecanemab (brand name: Leqembi), a disease-modifying…

Neurons often get most of the credit for keeping our brains sharp and functioning -- as well as most of the blame when it comes to brain diseases. But star-shaped cells called astrocytes,…

SOLANA BEACH, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery…

A novel, disease-modifying therapy for Alzheimer's disease may involve the whole exchange of blood, which effectively decreased the formation of amyloid plaque in the brains of mice,…

"This article provides a proof-of-concept for the utilization of technologies commonly used in medical practice, such as plasmapheresis or blood dialysis, to 'clean' blood from Alzheimer's…

A randomized trial presented at the recent Consortium of Multiple Sclerosis Centers (CMSC) annual meeting…